Jaisim Shah - Aug 30, 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
Director
Signature
/s/ Henry Ji, Ph.D., as attorney-in-fact
Stock symbol
SRNEQ
Transactions as of
Aug 30, 2021
Transactions value $
$0
Form type
4
Date filed
8/30/2021, 08:14 PM
Next filing
Nov 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock option (right to buy) Award $0 +250K $0.00 250K Aug 30, 2021 Common Stock 250K $8.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the original number of shares subject to this option shall vest and become exercisable on September 30, 2021, and 1/48th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.